iSOFT Signs Deals with Two Dutch Hospitals for €8.8 million

iSOFTIBA Health Group Limited (ASX: IBA), Australia's largest listed health information technology company, announced that its iSOFT European business has signed contracts with two major hospital groups in the Netherlands totalling €8.8 million ($17.6 million).

In the largest deal, Erasmus MC (medical center) in Rotterdam has renewed its contract for iSOFT's hospital information systems for a further five years. The $12.8 million (€6.4 million) contract includes licenses, maintenance and support. Erasmus MC is the university hospital of Rotterdam and the country's largest medical school with 1,500 students.

Hospital Diaconessenhuis Leiden, a major teaching hospital in Leiden, has also renewed its contract for iSOFT's hospital information systems and support in a three-year agreement worth $4.8 million (€2.4 million). During the contract period, Hospital Diaconessenhuis Leiden will work with iSOFT to improve the efficiency and effectiveness of patients' treatment.

Gary Cohen, IBA's Executive Chairman and CEO, said: "We are now seeing the benefits of our renewed commitment to servicing our customers in the Netherlands since the acquisition of iSOFT 15 months ago. We are winning their confidence, and expect more customers to follow."

Dr J G den Hollander, the Diaconessenhuis Leiden Hospital's director of operations, said: “iSOFT is a proven supplier providing trusted software applications, reliable support and trouble-free service.

"iSOFT's systems help us to improve the quality of information for clinical staff and quality of care for patients. These are also fundamental to improving efficiency and effectiveness while driving down costs," Dr den Hollander said.

Peter Herrmann, managing director of iSOFT Central Europe, said: "Our technologies not only create connections between existing systems, they create value by adding new functionality, and they're also designed to integrate perfectly with developing technologies over the coming years. That's the winning combination we provide - products that are both highly efficient and future-proof."

Related news articles:

About IBA Health Group
IBA Health Group Limited (ASX-IBA) is the largest health information technology company listed on the Australian Securities Exchange.

IBA builds software applications for healthcare. We work with healthcare professionals to design and build solutions that answer all of the difficult questions posed by today's care delivery challenges. Our solutions act as a catalyst for change, supporting the free exchange of critical information across diverse care settings and participant organisations. We are the leader in the provision of advanced application solutions in modern healthcare economies around the world.

Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market and anticipation of evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,000 specialists around the globe, including over 1,700 technology and development professionals.

A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result we offer our customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation and organisational structure.

For more information on IBA Health, please visit the company's website at www.ibahealth.com.

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...